scholarly article | Q13442814 |
P50 | author | Todd E. Peterson | Q42581285 |
P2093 | author name string | Ping Zhao | |
Jason R Buck | |||
H Charles Manning | |||
Daniel Colvin | |||
Eliot T McKinley | |||
Ronald M Baldwin | |||
Dewei Tang | |||
Allie Fu | |||
Ralph Adam Smith | |||
Saffet Guleryuz | |||
Mohammed Noor Tantawy | |||
Matthew R Hight | |||
Mohammed Sib Ansari | |||
P2860 | cites work | Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function | Q24296269 |
Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states | Q24631648 | ||
Microwave-assisted Organic Synthesis of a High-affinity Pyrazolo-pyrimidinyl TSPO Ligand | Q33650978 | ||
Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors | Q33985241 | ||
Imaging of a glioma using peripheral benzodiazepine receptor ligands | Q34594710 | ||
DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization | Q34769959 | ||
Distribution volume ratios without blood sampling from graphical analysis of PET data | Q36817029 | ||
Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. | Q37105874 | ||
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. | Q37283568 | ||
Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. | Q37449735 | ||
Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol | Q40971557 | ||
Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study | Q41134387 | ||
Imaging of brain tumors using peripheral benzodiazepine receptor ligands | Q41837734 | ||
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas | Q42465912 | ||
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. | Q43836608 | ||
Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer | Q44175762 | ||
Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. | Q46566192 | ||
Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. | Q46877954 | ||
Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain | Q48190498 | ||
Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors | Q48193416 | ||
COMKAT: compartment model kinetic analysis tool. | Q50126455 | ||
PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. | Q55484944 | ||
Isoquinoline and peripheral-type benzodiazepine binding in gliomas: implications for diagnostic imaging | Q68097881 | ||
Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor | Q73589795 | ||
Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation | Q80140819 | ||
Oral cancer, cigarette smoke and mitochondrial 18kDa translocator protein (TSPO) - In vitro, in vivo, salivary analysis | Q82565843 | ||
Cigarette Smoke Decreases Salivary 18 kDa Translocator Protein Binding Affinity – in Association with Oxidative Stress | Q84277258 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 107-114 | |
P577 | publication date | 2010-12-13 | |
P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
P1476 | title | Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline | |
P478 | volume | 52 |
Q37284537 | A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs. |
Q30945416 | Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use. |
Q64098498 | Anti-tumor effects and potential therapeutic response biomarkers in α-emitting -At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing |
Q48226866 | Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [18F]Fluoromethyl-PBR28 and [18F]CB251. |
Q39181546 | Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging |
Q34175347 | Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer |
Q38775990 | Imaging Macrophage Accumulation in a Murine Model of Chronic Pancreatitis with [(125)I]iodoDPA SPECT-CT. |
Q41446521 | New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO. |
Q36079268 | Noninvasive molecular imaging of neuroinflammation |
Q55456900 | Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma. |
Q35827097 | Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study |
Q35213599 | Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma |
Q37991245 | Pretargeting: taking an alternate route for localizing radionuclides |
Q27023605 | Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging |
Q36081687 | Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. |
Q39225240 | SPECT imaging of glioma with radioiodinated CLINDE: evidence from a mouse GL26 glioma model |
Q34632108 | Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging |
Q38640193 | TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma |
Q48194480 | TSPO PET using 18F-GE-180: a new perspective in neurooncology? |
Q26748489 | TSPO expression in brain tumours: is TSPO a target for brain tumour imaging? |
Q45401909 | The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO). |
Q38014892 | The impact of positron emission tomography imaging on the clinical management of patients with epilepsy |
Q30618244 | The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches |
Q38221277 | The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy. |
Q39407528 | The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo |
Q38617821 | Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model |
Q38949384 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1). |
Q35048800 | Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity |
Q39009678 | Translocator protein 18 kDa negatively regulates inflammation in microglia |
Search more.